|
USP36 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.64099999999867E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55890000019809E-07 |
| Normal-vs-Stage2 |
4.808400E-02 |
| Normal-vs-Stage3 |
5.588100E-02 |
| Normal-vs-Stage4 |
4.995800E-02 |
| Stage1-vs-Stage2 |
8.449600E-02 |
| Stage1-vs-Stage3 |
2.379200E-03 |
| Stage1-vs-Stage4 |
1.426120E-02 |
| Stage2-vs-Stage3 |
6.140400E-01 |
| Stage2-vs-Stage4 |
7.524000E-01 |
| Stage3-vs-Stage4 |
8.350200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.209000E-04 |
| Normal-vs-AfricanAmerican |
6.30099999999745E-05 |
| Normal-vs-Asian |
8.767400E-04 |
| Caucasian-vs-AfricanAmerican |
9.922300E-03 |
| Caucasian-vs-Asian |
7.644000E-02 |
| AfricanAmerican-vs-Asian |
8.520000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.175200E-03 |
| Normal-vs-Female |
5.80629999635818E-08 |
| Male-vs-Female |
1.597380E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.631220E-01 |
| Normal-vs-Age(41-60Yrs) |
4.83470000001152E-06 |
| Normal-vs-Age(61-80Yrs) |
7.622600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.852370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.315600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.598600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.589600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.767030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.201200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.262200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.155000E-04 |
| Normal-vs-Grade 2 |
2.99510000023595E-07 |
| Normal-vs-Grade 3 |
2.294200E-02 |
| Normal-vs-Grade 4 |
1.383550E-01 |
| Grade 1-vs-Grade 2 |
2.083600E-03 |
| Grade 1-vs-Grade 3 |
3.3476999999893E-06 |
| Grade 1-vs-Grade 4 |
3.55480000000519E-05 |
| Grade 2-vs-Grade 3 |
1.102890E-03 |
| Grade 2-vs-Grade 4 |
5.355800E-03 |
| Grade 3-vs-Grade 4 |
5.967800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.28649999728981E-08 |
| Normal-vs-ccB subtype |
4.331900E-02 |
| ccA subtype-vs-ccB subtype |
2.235200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.767800E-04 |
| Normal-vs-N1 |
1.239410E-01 |
| N0-vs-N1 |
7.855400E-01 |
|
|
